Network-based Approach in Type 2 Diabetes and Its Cardiovascular Risk
NCT03792607 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 35
Last updated 2019-09-18
Summary
PIRAMIDE study design will test the hypothesis that simultaneous interactions between DNA methylation and microRNAs may hit T2D candidate genes and predict the development of T2D-related cardiovascular complications.
Conditions
Sponsors & Collaborators
-
Giuditta Benincasa
lead OTHER
Principal Investigators
-
Giuditta Benincasa, MSc · Clinical Department of Internal Medicine and Specialistics
Eligibility
- Min Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-02-14
- Primary Completion
- 2020-01-14
- Completion
- 2020-06-14
Countries
- Italy
Study Locations
More Related Trials
-
Screening for Undiagnosed Type 2 Diabetes in New Classes of Subjects at High Risk
NCT00520962 ·Status: COMPLETED
-
Macrophage Phenotype in Type 2 Diabetics After Myocardial Infarction and the Potential Role of miRNAs Secreted
NCT02768935 ·Status: COMPLETED ·Phase: NA
-
Metabolic Characteristics of Type 2 Diabetes Mellitus Combined With Acute Myocardial Infarction: A Untargeted Metabolomics Study
NCT05601310 ·Status: COMPLETED
-
Role of Circulating Pyrophosphate as a Biomarker of Mediacalcinosis in Type 2 Diabetic Patients
NCT07005986 ·Status: RECRUITING ·Phase: NA
-
SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Prospective, Multi-center Registry Study
NCT05770687 ·Status: RECRUITING
-
Vascular Dysfunction in Diabetes: Genes and Hormones
NCT01511042 ·Status: TERMINATED
-
Phenotyping Individuals With Neo-diagnosed Type 2 Diabetes at Risk for All-cause Mortality
NCT04453605 ·Status: COMPLETED
-
DHS MIND Metabolomics
NCT03975309 ·Status: COMPLETED
-
A Study of Blood Metabolic Markers in Patients With Type 2 Diabetes Mellitus of Different Stages
NCT06155539 ·Status: NOT_YET_RECRUITING
-
Personalized Medicine for Diabetes Prediction and Prevention of Complications
NCT01268813 ·Status: UNKNOWN ·Phase: PHASE1
-
Diabetes Complications and the Risk of Cardiovascular and Cerebrovascular Diseases
NCT04983277 ·Status: NOT_YET_RECRUITING
-
Mechanisms of Pro-Thrombosis in Diabetes Mellitus -- Ancillary to BARI 2D
NCT00041405 ·Status: COMPLETED
-
Mitochondrial Substrate Utilization in the Diabetic Human Heart
NCT05958706 ·Status: RECRUITING
-
Effect of Mutations in T2DM Susceptibility Genes on the Expression of Susceptibility Genes in Patients With T2DM and Controls
NCT06277466 ·Status: RECRUITING ·Phase: NA
-
Clinical Phenotype and Outcomes of Inpatients With COVID-19 and Diabetes
NCT04550403 ·Status: COMPLETED
-
Assessing Incretin Therapy for Cardiovascular Risk Reduction and Diabetes Remission( ITCRDR Study)
NCT06959784 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Salivary Transcriptome Biomarkers for Early Diabetes Detection
NCT02673762 ·Status: UNKNOWN
-
Atherothrombosis Markers in Diabetics
NCT02898467 ·Status: UNKNOWN
-
Study on the Predictive Value of High-sensitivity Cardiac Troponin I, N-terminal Pro-B-natriuretic Peptide, and Soluble Suppression of Tumorigenesis-2 for Mortality and the Development of Cardiovascular Events in Patients With Type 2 Diabetes (Diabetes-CV)
NCT06902857 ·Status: RECRUITING
-
The DIAMOND® for the Treatment of Type 2 Diabetes
NCT02079376 ·Status: UNKNOWN ·Phase: NA
-
Cohort Study in Type 2 Diabetes in China
NCT01076023 ·Status: UNKNOWN
-
Precision Medicine for Preventing Type 2 Diabetes: a Step Forward
NCT05147961 ·Status: RECRUITING ·Phase: NA
-
Metformin in the Diastolic Dysfunction of Metabolic Syndrome
NCT02017561 ·Status: COMPLETED ·Phase: PHASE2
-
Plasma Dipeptidyl-peptidase-4 Activities With No-reflow and Bleeding
NCT02849691 ·Status: COMPLETED
-
SGLT2 Inhibitor Use After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Nationwide Cohort Study
NCT07198191 ·Status: ACTIVE_NOT_RECRUITING